The Law Offices of Frank R. Cruz reminds investors of the upcoming October 21, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired DexCom, Inc. ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

On Tuesday, DexCom Inc (DXCM) stock saw a decline, ending the day at $67.1 which represents a decrease of $-2.08 or -3.01% from the prior close of $69.18. The stock opened at $69 and touched a low of ...

Normoglycemic individuals spent 87% of their daily time in in the “tight range” of glucose levels (70-140 mg/dL) and the remainder above 140 mg/dL.

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

How is QQQ stock faring? The Invesco QQQ ETF is up 0.03% in the past five days and has risen about 22.01% year-to-date.

DexCom's key Q3 earnings factors include Stelo sales, updates on sales channels, and potential share buybacks. See why I ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...

A 10-year-old boy from New Town has been living life to the fullest despite his recent diagnosis of Type 1 diabetes.

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...

Reportedly in the works for future versions of the Apple Watch: Blood pressure monitoring and blood glucose readings.

People with Type 1 diabetes can connect their Dexcom blood-glucose sensor — an FDA-approved medical device — directly to ...